Table of Contents Table of Contents
Previous Page  449 / 1096 Next Page
Information
Show Menu
Previous Page 449 / 1096 Next Page
Page Background

S434

ESTRO 36

_______________________________________________________________________________________________

Figure

1

Conclusion

It is shown that the MAASTRO algorithm implementation

for gamma analysis based on absolute dose comparison is

reliable and provides very good results for both types of

plans tested. When compared with the results obtained

with PDIP v10.0.28, the MAASTRO algorithm presents at

least as good results for the pre-treatment portal

dosimetry as the currently available PDIP, while reporting

absolute dose results, making it a viable, and even

desirable, alternative.

PO-0811 Monte Carlo simulation of peripheral dose for

Gamma Knife treatments

B. Sanchez-Nieto

1

, E. Doerner

1

, A.M. Cardona

1

, F. Bova

2

1

Pontificia U-dad Catolica de Chile, Insitute of Physics,

Santiago, Chile

2

Gamma knife Chile, Radiotherapy, Santiago, Chile

Purpose or Objective

Induction of second cancers after external beam

radiotherapy (RT) is associated to the dose deposited

outside the treatment field (Peripheral Dose -PD)

[1]

. New

advances in radiation oncology have increased the survival

of patients beyond the period of latency of the occurrence

of secondary cancer (> 5 years), so that the estimation of

PDs has become particularly relevant. Commercial

treatment planning systems present a great uncertainty in

the dose calculation outside the treatment field

(differences up to 50%)

[2]

; therefore, alternative

methodologies for estimation of PD to radiosensitive

organs are needed. There are previous studies

[3,4]

applicable to external RT with linear accelerators.

However, no such a model exists for Gamma Knife. The

aim of this study was to estimate the peripheral dose

associated to radiosurgery treatments using Monte Carlo

(MC) and experimental measurements with TLDs.

Material and Methods

A Leksell Gamma Knife 4C radiosurgery equipment was

modeled using the set of C++ libraries Egspp, part of the

MC platform EGSnrc. The model includes the entire set of

201 Cobalt-60 sources, along with their respective beam

channel. Validation was performed by comparing profiles

and dose deposited in depth during irradiation of the Lucy

QA Phantom with all sources opened. Then, the photon

spectrum and absorbed dose were calculated and

measured with TLD-100 pairs, for the plan above, at 14

points of a pseudo-anthropomorphic phantom. TLD-100

had calibration factors for 6 MV nominal energy. TLD

readings were corrected by an energy response correction

factor due to the change in response from the 6 MV

calibration beam to the softened spectrum at the

measurement points.

Results

The simulated geometry was tested using a raytracing

method, included in Egspp, which allowed visualization of

geometrical details to be compared with the available

technical drawings. Difference of just 3.5 % was obtained

for the experimental and calculated FWHM. Mean energies

calculated from peripheral photon spectra energies

ranged from 0.242 MeV in the mediastinum to 0.171 MeV

in the pelvis. Based on these results, an average energy

correction factor of 10% was applied to TLD readings. A

maximum of 15% difference between calculated and

measured peripheral doses were obtained.

Conclusion

The use of Egspp allowed us to model accurately the

Gamma Knife. The level of detail achieved in the modeled

geometry is essential for the peripheral dose calculation,

since it is dependent on the radiation leakage. The

agreement between simulations and measurements is

good, with higher discrepancies observed in the points

located on the limbs of the phantom. A MC methodology

for peripheral dose characterization has been validated

and therefore, different scenarios regarding patient size

and/or beam geometry can be estimated for future

references.

References

[1] Radiother Oncol 2012;10(5):122-126

[2] JACFMP, vol 14, N2, 2013

[3] Phys. Med. Biol. 57 (2012) 6167–6191

[4] Biomed. Phys. Eng. Express 1 (2015) 045205

PO-0812 Dosimetric impact of using Acuros algorithm

for stereotactic lung and spine treatments

L. Vieillevigne

1,2

, T. Younes

1,2

, A. Tournier

1

, P. Graff

Cailleaud

1

, C. Massabeau

1

, J.M. Bachaud

1

, R. Ferrand

1,2

1

Institut Claudius Regaud- Institut Universitaire du

Cancer de Toulouse Oncopole, Radiophysique, Toulouse,

France

2

Centre de Recherche et de Cancérologie de Toulouse

CRCT- UMR1037 INSERM - Université Toulouse 3,

Radiophysique- équipe 15, Toulouse, France

Purpose or Objective

The main aim was to assess the dosimetric impact of

calculating with the Acuros (AXB) algorithm instead of

Anisotropic Analytical Algorithm (AAA) for stereotactic

(SBRT) lung and spine cancer treatments.

Material and Methods

Ten stereotactic lung patients and ten stereotactic spine

patients were selected to investigate the dosimetric

impact of using AXB instead of AAA. Dynamic conformal

arc was used for SBRT lung patients with a prescription of

50 to 55 Gy in 3 or 5 fractions to the 80% isodose. For the

SBRT spine patients, Rapid Arc plans were prepared and

27 Gy was prescribed in 3 fractions to the PTV median

dose. The plans were recalculated with the AXB algorithm

by using the same beam settings and monitor units as the

AAA. Two dose reporting modes of AXB, dose to medium

(Dm) and dose to water (Dw) were studied. Relative dose

differences between algorithms were calculated for PTV

(D98%, D95%, D50% and D2%) and for organs at risk (D2%

and mean dose for the ipsilateral lung, the spinal cord or

the cauda equina).

Results

For the 10 SBRT lung patients, the mean lung density was

around 0.18 g/cm

3

which corresponded to a normal lung

tissue. The dosimetric impact on PTV dose (D98%, D95%,

D50%) using AXB instead of AAA was quite small with a

maximum underdosage up to 3.1% for D98%. Larger

differences were obtained on D2% with a maximum

deviation of 7.79%. The average difference on the mean

ipsilateral lung dose was 0.22% and 0.44% for AXBDm and

AXBDw, respectively. AXBDm and AXBDw presented similar

results.

For the 10 SBRT spine patients, large relative dose

disagreement of up to -5.02% for the D98% of the PTV was

observed with AXBDm. On average, for the D50% of the

PTV, AXBDm revealed a relative underdosage of -2.36%,

whereas AXBDw lead to a relative overdosage of +1.64%.

Concerning the spinal cord or the cauda equina, the

average mean dose was reduced up to -6.93% and up to -